VOR Stock Analysis: Buy, Sell, or Hold?
VOR - Vor Biopharma Inc. Common Stock
$23.03
-0.26 (-1.12%)
▼
5d:
-2.7%
30d:
+32.81%
90d:
+52.82%
WAIT
LOW Confidence
Analysis Updated: Aug 14, 2026 12:00 AM ET
Earnings: Aug 11, 2026
0d
Get Alerted When VOR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: VOR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: VOR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: VOR is currently trading at $23.03, which is considered extended relative to its 30-day fair value range of $18.43 to $22.24.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $20.17, while resistance sits at $24.34.
Market Sentiment: VOR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.88 (+62.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, VOR is in a strong uptrend. Immediate support is located at $20.17, while resistance sits at $24.34.
Market Sentiment: VOR scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $37.88 (+62.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$18.43 -
$22.24
Company Quality Score
39/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
26.3%
All Signals
- BEARISH: Price extended above range
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.6% below Wall St target ($37.88)
- WARNING: Composite score 38/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$18.43 -
$22.24
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$20.17
Resistance Level
$24.34
Current Trend
Strong Uptrend
Technical data as of
Aug 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.22
Wall Street Target
$37.88
(+62.6%)
Share & Embed Analysis
Last updated: August 16, 2026 1:56 AM ET
Data refreshes hourly during market hours. Next update: 2:56 AM
Data refreshes hourly during market hours. Next update: 2:56 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is VOR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
11
Sells
Net
INSIDERS SELLING
Recent Transactions
Ra Capital Management, L…
SELL
165150 shares
2026-04-22
Ra Capital Management, L…
SELL
171963 shares
2026-04-20
Ra Capital Management, L…
SELL
458411 shares
2026-04-17
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$376 | 49 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$431 | 33 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$559 | 32 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$309 | 52 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
